Evidence map›Paper›PMID 39066205›Full record

ArticleViruses2024

Dynamic Changes in Viral Loads during Co-Infection with a Recombinant Turkey Herpesvirus Vector Vaccine and Very Virulent Marek's Disease Virus In Vivo.

Tian Ding, Min Xiong, Yang Xu, Xing Pu, Qin-Sen Wang, Mo-Ru Xu, Hong-Xia Shao, Kun Qian, Hai-Bin Dang, Ai-Jian Qin

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tian DingThe Ministry of Education Key Laboratory for Avian Preventive Medicine, Yangzhou University, Yangzhou 225009, China.
Min XiongThe Ministry of Education Key Laboratory for Avian Preventive Medicine, Yangzhou University, Yangzhou 225009, China.
Yang XuCollege of Veterinary Medicine, Sichuan Agricultural University, Chengdu 625014, China.
Xing PuNanchang Boehringer-Ingelheim Animal Health Co., Ltd., Nanchang 330096, China.
Qin-Sen WangThe Ministry of Education Key Laboratory for Avian Preventive Medicine, Yangzhou University, Yangzhou 225009, China.
Mo-Ru XuThe Ministry of Education Key Laboratory for Avian Preventive Medicine, Yangzhou University, Yangzhou 225009, China.
Hong-Xia ShaoThe Ministry of Education Key Laboratory for Avian Preventive Medicine, Yangzhou University, Yangzhou 225009, China.
Kun QianThe Ministry of Education Key Laboratory for Avian Preventive Medicine, Yangzhou University, Yangzhou 225009, China.ORCID 0000-0002-8900-1848
Hai-Bin DangNanchang Boehringer-Ingelheim Animal Health Co., Ltd., Nanchang 330096, China.
Ai-Jian QinThe Ministry of Education Key Laboratory for Avian Preventive Medicine, Yangzhou University, Yangzhou 225009, China.ORCID 0000-0001-5779-273X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marek's disease (MD), caused by the Marek's disease virus (MDV), is a common infectious tumor disease in chickens and was the first neoplastic disease preventable by vaccination. However, the vaccine cannot completely prevent virulent MDV infections, allowing both the vaccine and virulent MDV to coexist in the same chicken for extended periods. This study aims to investigate the changes in viral load of the very virulent strain Md5 and the rHVT-IBD vaccine in different chicken tissues using a real-time PCR assay. The results showed that the rHVT-IBD vaccine significantly reduced the viral load of MDV-Md5 in different organs, while the load of rHVT-IBD was significantly increased when co-infected with Md5. Additionally, co-infection with Md5 and rHVT-IBD in chickens not only changed the original viral load of both viruses but also affected the positive rate of Md5 at 14 days post-vaccination. The positive rate decreased from 100% to 14.29% (feather tips), 0% (skin), 33.33% (liver), 16.67% (spleen), 28.57% (thymus), 33.33% (bursa), and 66.67% (PBL), respectively. This study enhances our understanding of the interactions between HVT vector vaccines and very virulent MDV in chickens and provides valuable insights for the future development of MD vaccines.

Indexed as

ChickensCoinfectionMarek DiseaseMarek Disease VaccinesPoultry DiseasesViral LoadAnimalsGenetic VectorsHerpesvirus 1, MeleagridHerpesvirus 2, GallidVaccinationVaccines, SyntheticVirulenceMarek Disease VaccinesVaccines, SyntheticMarek’s disease virusMd5rHVT-IBD vaccineviral load

Identifiers

PMID39066205
PMCPMC11281522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.